Literature DB >> 20846793

Concomitant adenocarcinoma and colonic non-Hodgkin's lymphoma in a patient with ulcerative colitis: a case report and molecular analysis.

Takashi Nishigami1, Tatsuki R Kataoka, Ikuko Torii, Ayuko Sato, Kazuo Tamura, Hiroshi Hirano, Nobuyuki Hida, Hiroki Ikeuchi, Tohru Tsujimura.   

Abstract

Ulcerative colitis (UC) complicated by colonic lymphoma is rare, although UC is often accompanied by adenocarcinoma of the colon. A concurrent existence of adenocarcinoma and lymphoma in a patient with UC is extremely rare, and has not yet been analyzed at the molecular level. We report a 64-year-old female patient with concomitant adenocarcinoma and diffuse large B-cell lymphoma (DLBCL) in the colon of UC. The genetic changes in these two neoplasms were analyzed. The colon adenocarcinomas had a mutation in MSH6 gene, DNA methylation in CDKN2A gene, and increased microsatellite instability (MSI), although these genetic changes were not recognized in either DLBCL or non-neoplastic UC mucosa. The DLBCL was diagnosed as primary colonic lymphoma, and confirmed Epstein-Barr virus (EBV) infection. The adenocarcinomas and the non-neoplastic UC mucosa were EBV-negative. Our case presented here clearly shows that the development of adenocarcinoma and lymphoma in the colon with UC was caused by individual mechanisms.
Copyright © 2010 Elsevier GmbH. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20846793     DOI: 10.1016/j.prp.2010.07.007

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  2 in total

Review 1.  Human Papillomaviruses and Epstein-Barr Virus Interactions in Colorectal Cancer: A Brief Review.

Authors:  Queenie Fernandes; Ishita Gupta; Semir Vranic; Ala-Eddin Al Moustafa
Journal:  Pathogens       Date:  2020-04-20

Review 2.  Epstein-Barr Virus in the Development of Colorectal Cancer (Review).

Authors:  N A Oleynikova; N V Danilova; M O Grimuta; P G Malkov
Journal:  Sovrem Tekhnologii Med       Date:  2021-08-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.